Работы, цитирующие эту работу

Работ: 2

Работа: Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment

1. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

   Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim +7

   Обзорная статьяCAR-T cell therapy researchCritical Reviews in Oncology/Hematology2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.review-article.000011

2. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

   Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

   СтатьяCancer Immunotherapy and BiomarkersClinical & Translational Oncology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.002768